Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research
Big effect

In a pediatric obesity review, L-carnitine beat other supplements for cutting BMI and waist size — but the findings come from a clinical population that may not reflect everyday use.

This is the strongest signal yet for L-carnitine on weight and metabolic markers, but it's based on moderate-strength evidence from only six studies in a clinical pediatric setting, so don't assume the same effect in healthy adults supplementing on their own.

A systematic review of nutraceuticals in obese children and adolescents found L-carnitine consistently reduced body weight, BMI, waist circumference, blood sugar, insulin resistance, and LDL cholesterol, while raising HDL — making it the standout supplement among those tested. However, the results come from a clinical population under medical supervision, not from a general healthy adult group, and the review didn't specify the dose used, so the practical takeaway is limited.

Where this fits in the evidence

Pillser has synthesized 6 studies on L-Carnitine for Reduced Body Mass Index — overall evidence strength: Moderate.

Across 6 studies (4 meta-analyses, 1 systematic review, 1 review), 4 reported a beneficial small effect of L-carnitine on reducing body mass index, while 2 found no significant effect. The most studied dose range was 1–2 g/day, and effects were typically observed in clinical populations (e.g., type 2 diabetes, overweight/obesity) over a median duration of 56 days (8 weeks). The predominant effect size is small, with one study reporting a moderate effect.

This is a plain-language summary of a research finding, not medical advice. Pillser surfaces research signals to help you decide what's worth investigating — always consult a qualified professional before changing what you take.

Back to top